当前位置:首页  师资队伍  技术支撑队伍


李廷栋,理学博士,高级工程师


教育经历

2014年毕业于厦门大学生命科学学院生物化学与分子生物学专业,获理学博士学位;

2006年毕业于厦门大学生命科学学院生物技术专业,获理学学士学位;

工作经历

2015年起任职榴莲官网自直接进入国家传染病诊断试剂与疫苗工程技术研究中心。


主要研究方向

  1. 轮状病毒基因工程疫苗的研究;

  2. EB病毒与鼻咽癌发生、发展的关系的研究;

  3. 人巨细胞病毒流行病学及先天性感染风险评估方法的研究。


通信地址:厦门大学翔安校区国家传染病诊断试剂与疫苗工程技术研究中心(椭圆楼)253

邮编:361102

电子邮箱: litingdong@xmu.edu.cn


代表性论文

  1. Li Y, Xue M,Yu L, Luo G, Yang H, Jia L, Zeng Y, Li T*, Ge S* and Xia N, Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine. Vaccine, 2018. 36(16): p. 2086-2092.

  2. Li T#, Guo X#, Ji M#, Li F, Wang H, Cheng W, Chen H, Ng M, Ge S*, Yuan Y*, and Xia N, Establishment and validation of a two-step screening scheme for improved performance of serological screening of nasopharyngeal carcinoma. Cancer Med, 2018. 7(4): p. 1458-1467.

  3. Zhang, C, Huang X, Chen S, Li Y, Li Y, Wang X, Tang J, Xia L, Lin Z, Luo W, Li T, Li S, Zhang J, Xia N*, and Zhao Q*, Epitope clustering analysis for vaccine-induced human antibodies in relationship to a panel of murine monoclonal antibodies against HPV16 viral capsid. Vaccine, 2018. 36(45): p. 6761-6771.

  4. Huang Y#, Guo X#, Song Q#, Wang H, Yu H, Zhang Y, Qiao E, Xue W, Li X, Zhuang S, Wei F, Li T, Ge S, Wu T, Xia N, and Zhang J*, Cytomegalovirus Shedding in Healthy Seropositive Female College Students: A 6-Month Longitudinal Study. J Infect Dis, 2018. 217(7): p. 1069-1073.

  5. Li, T, Li J, Huang X, Wang H, Guo X, Ge S*, and Zhang J*, Baseline antibody level may help predict the risk of active human cytomegalovirus infection in a HCMV seropositive population. Eur J Clin Microbiol Infect Dis, 2017. 36(5): p. 863-868.

  6. Huang, X, Li J, Ge S*, Li T, Wang H, Guo X, Fu T, and Zhang J, Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp150 antigen. Journal of Virological Methods, 2017. 240: p. 21-25.

  7. Xue, M, Yu L, Jia L, Li Y, Zeng Y, Li T*, Ge S*, and Xia N, Immunogenicity and protective efficacy of rotavirus VP8* fused to cholera toxin B subunit in a mouse model. Hum Vaccin Immunother, 2016. 12(11): p. 2959-2968.

  8. Xue M, Yu L, Che Y, Lin H, Zeng Y, Fang M, Li T*, Ge S*, Xia N. Characterization and protective efficacy in an animal model of a novel truncated rotavirus VP8 subunit parenteral vaccine candidate. Vaccine 2015; 33:2606-13.

  9. Li T, Lin H, et al. Development of an Enzyme-Linked Immunospot (Elispot) Assay for determination of rotavirus infectivity [J]. JVM, 2014, 209: 7-14.

  10. Li T, Lin H, Zhang Y, et al. Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles [J]. Vaccine, 2014, 32(17):1921-1931.